Moderna's melanoma vaccine is generating buzz after a Phase 3 breakthrough. But can it actually cure skin cancer? What ...

People given the experimental vaccine with standard treatment lived longer without their cancer returning, the companies ...

The trial met both endpoints in the readout, removing the inconclusive outcome management itself had flagged, and short ...

CBS News medical correspondent Dr. Céline Gounder, who has had melanoma herself, said Moderna's experimental trial is "a big ...

A personalized mRNA vaccine for melanoma reduced the risk of the cancer returning in a phase III clinical trial, the ...

The companies have not published the trial data but said in a news release that the experimental treatment extended the time ...

Moderna and Merck said their personalized cancer treatment showed positive results in their first-ever late-stage trial. Here ...

Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of ...

A personalized mRNA cancer vaccine combined with the immunotherapy Keytruda succeeded in a late-stage trial for the deadly ...

Moderna has been looking for its next blockbuster drug after a wildly successful COVID era.